A carregar...
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Protein Glycan Coupling Technology (PGCT) uses purposely modified bacterial cells to produce recombinant glycoconjugate vaccines. This vaccine platform holds great potential in this context, namely due to its modular nature, the simplified production process in comparison to traditional chemical con...
Na minha lista:
| Publicado no: | Microb Cell Fact |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142613/ https://ncbi.nlm.nih.gov/pubmed/34030723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-021-01588-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|